Double-headed arrow (between “Obstructive sleep apnea syndrome” and “Obesity”): This indicates a bidirectional relationship between Obstructive sleep apnea syndrome and obesity. Intermittent hypoxia ...
Cardiovascular diseases remain a leading cause of mortality globally, particularly among individuals with both obstructive sleep apnea (OSA) and metabolic syndrome (MetS). These two conditions ...
Sleep breathing disorders (SBDs)—including obstructive sleep apnoea, central sleep apnoea and sleep-related hypoventilation syndromes—represent a major yet under-recognised contributor to global ...
Mark Bleackley, PhD, chief scientific officer of Incannex, discusses in further detail the need for a pharmacotherapy like IHL-42X in obstructive sleep apnea (OSA) and the medication's underlying ...
Will the weight reduction successes seen with use of glucagon-like peptide 1 (GLP-1) agonists translate into improvement in obstructive sleep apnea (OSA)? Will those potential OSA benefits reduce the ...
Patients with ischemic stroke and obstructive sleep apnea (OSA) have elevated fibrinogen levels, which correlate positively with apnea severity, suggest Wessendorf et al in a paper published in the ...
Several birth cohorts have defined the pivotal role of early lower respiratory tract infections (LRTI) in the inception of pediatric respiratory conditions. However, the association between early LRTI ...
Obstructive sleep apnea (OSA) is a serious, chronic sleep-related breathing disease that impacts an estimated 80 million people in the United States and nearly 1 billion globally. Untreated OSA ...
Individuals with psoriasis have a 20% higher risk of developing OSA, even after adjusting for common risk factors. The study utilized a large dataset, enhancing the generalizability of its findings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results